Compare Incyte Corporation (INCY) vs United Parcel Service Inc (UPS) Price & Performance

Incyte (INCY) trades at $112.75, down 0.61% on the day, with a bearish technical signal despite strong fundamentals. The company reported robust 2025 results with $5.14B revenue and $1.29B net income, showing significant margin expansion. Recent FDA approval for Atebrioz and pipeline progress support growth prospects beyond JAKAFI's 2029 exclusivity loss. Analyst consensus is bullish with a $132.43 price target, though technical indicators show selling pressure near key resistance.

Outlook remains positive driven by pipeline diversification and operational leverage, but near-term technical weakness and reliance on JAKAFI transition pose risks. The stock offers value with a 14.36 P/E ratio and strong profitability metrics, though investors should monitor execution on the $4B non-JAKAFI sales target and quarterly earnings consistency.

UPS trades at $94.11, up 1.98% on the day, amid a mixed technical and fundamental backdrop. The stock's valuation appears reasonable with a P/E of 17.5 and P/S of 0.89, while profitability metrics like a 29.66% ROE remain strong. Recent earnings have consistently beaten expectations, but revenue and net income have trended lower since 2022. Analyst sentiment is divided, with a consensus price target of $118.67 suggesting significant upside, though technical indicators signal a near-term bearish trend.

The investment case hinges on margin improvement and cost control offsetting volume pressures. The near 7% dividend yield provides income support, but risks include competitive threats from Amazon, volatile fuel costs, and potential further earnings estimate revisions. Upside is contingent on a reversal of the bearish technical trend and stabilization of fundamentals.